ESR1 ligand-binding domain mutations in hormone-resistant breast cancer (Q27852637)

7

0 references

Yang Shen

object named as

Yang Shen

2

0 references

Geoffrey L Greene

15

object named as

Geoffrey Greene

0 references

author name string

Helen Won

3

0 references

Bradley Green

4

0 references

Rita A Sakr

5

0 references

Marie Will

6

0 references

Kinisha Gala

8

0 references

Sean Fanning

9

0 references

Tari A King

10

0 references

Clifford Hudis

11

0 references

David Chen

12

0 references

Tetiana Taran

13

0 references

Gabriel Hortobagyi

14

0 references

Michael Berger

16

0 references

José Baselga

17

0 references

Sarat Chandarlapaty

Comprehensive molecular portraits of human breast tumours

18

0 references

language of work or name

English

0 references

publication date

December 2013

0 references

published in

Nature Genetics

0 references

volume

45

0 references

issue

12

0 references

page(s)

1439-45

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Fast and accurate short read alignment with Burrows-Wheeler transform

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

CHARMM: the biomolecular simulation program

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

HER-2 gene amplification can be acquired as breast cancer progresses

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Molecular basis of agonism and antagonism in the oestrogen receptor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

All-atom empirical potential for molecular modeling and dynamics studies of proteins

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

The Sequence Alignment/Map format and SAMtools

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Scalable molecular dynamics with NAMD

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Molecular determinants for the tissue specificity of SERMs

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Estrogen Receptors as Therapeutic Targets in Breast Cancer

20 March 2017

1 reference

Crossref

https://api.crossref.org/works/10.1038/NG.2822

VMD: visual molecular dynamics

22 April 2017

1 reference

Crossref

https://api.crossref.org/works/10.1038/NG.2822

A framework for variation discovery and genotyping using next-generation DNA sequencing data

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Integrative genomics viewer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Estrogen receptors as therapeutic targets in breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Advances in adjuvant hormonal therapy for postmenopausal women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903423

Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24185512

12 December 2020

inferred from PubMed ID database lookup

An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24185512

12 December 2020

inferred from PubMed ID database lookup

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.2822

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NG.2822

1 reference

Dimensions Publication ID

268016

1019741899

0 references

Fatcat ID

release_litkw7orl5efpogia7j5e7bswq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/litkw7orl5efpogia7j5e7bswq

24 November 2022

mapped directly with Wikidata item

268016

1 reference

1 reference

1 reference